Onconetix, Inc. — Director's Dealing 2024

Oct 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-09-26

Reporting Person: Ramdeen Timothy R. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-26	Common Stock	A	3318	—	Acquired	3477	Direct

Footnotes

F1: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.